AWA
Arete Wealth Advisors Portfolio holdings
AUM
$1.41B
This Quarter Return
-13%
1 Year Return
+21.07%
3 Year Return
+57.28%
5 Year Return
+93.44%
10 Year Return
+188.14%
AUM
$989M
AUM Growth
+$989M
(-17%)
Cap. Flow
-$88.7M
Cap. Flow
% of AUM
-8.97%
Top 10 Holdings %
Top 10 Hldgs %
29.26%
Holding
587
New
81
Increased
192
Reduced
170
Closed
135
Top Buys
| 1 |
United States Antimony
UAMY
|
$37.4M |
| 2 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
$17.6M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$12.6M |
| 4 |
Vanguard Growth ETF
VUG
|
$12.5M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$12M |
Top Sells
| 1 |
AbbVie
ABBV
|
$41.8M |
| 2 |
Vanguard Total International Stock ETF
VXUS
|
$33.7M |
| 3 |
FS KKR Capital
FSK
|
$14.2M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
$13.6M |
| 5 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
$12.5M |
Sector Composition
| 1 | Materials | 4.77% |
| 2 | Technology | 4.53% |
| 3 | Financials | 4.17% |
| 4 | Consumer Discretionary | 2.84% |
| 5 | Healthcare | 2.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
BlackRock MuniYield Quality Fund
MQY
$792M
| – | – |
-203,687
| Closed | -$2.81M |
|
577
iShares MSCI USA Momentum Factor ETF
MTUM
$18B
| – | – |
-1,675
| Closed | -$282K |
|
|
OAK
578
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| – | – |
-22,576
| Closed | -$993K |
|
579
Nuveen Quality Municipal Income Fund
NAD
$2.64B
| – | – |
-124,242
| Closed | -$1.66M |
|
|
NBH
580
Neuberger Berman Municipal Fund
NBH
$292M
| – | – |
-33,385
| Closed | -$443K |
|
581
Nektar Therapeutics
NKTR
$543M
| – | – |
-11,000
| Closed | -$59K |
|
582
Annaly Capital Management
NLY
$13.8B
| – | – |
-19,348
| Closed | -$136K |
|
583
Intellia Therapeutics
NTLA
$1.26B
| – | – |
-2,874
| Closed | -$209K |
|
584
Nutrien
NTR
$27.6B
| – | – |
-2,354
| Closed | -$245K |
|
585
Northern Trust
NTRS
$24.7B
| – | – |
-4,505
| Closed | -$525K |
|
586
Nuveen Municipal Value Fund
NUV
$1.81B
| – | – |
-12,583
| Closed | -$121K |
|
587
Novartis
NVS
$248B
| – | – |
-3,530
| Closed | -$310K |
|